BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Moodys
Dow
AstraZeneca
Cipla
Mallinckrodt
Deloitte
Colorcon
Medtronic
Harvard Business School
Farmers Insurance

Generated: January 17, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020743

« Back to Dashboard

NDA 020743 describes NORITATE, which is a drug marketed by Valeant Pharms North and is included in one NDA. It is available from two suppliers. Additional details are available on the NORITATE profile page.

The generic ingredient in NORITATE is metronidazole. There are eighteen drug master file entries for this compound. Eighty-four suppliers are listed for this compound. Additional details are available on the metronidazole profile page.
Summary for 020743
Tradename:NORITATE
Applicant:Valeant Pharms North
Ingredient:metronidazole
Patents:0
Therapeutic Class:Antibacterials
Formulation / Manufacturing:see details
Pharmacology for NDA: 020743
Ingredient-typeNitroimidazoles
Medical Subject Heading (MeSH) Categories for 020743
Suppliers and Packaging for NDA: 020743
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
NORITATE metronidazole CREAM;TOPICAL 020743 NDA Valeant Pharmaceuticals North America LLC 0187-5202 0187-5202-60 60 g in 1 TUBE (0187-5202-60)
NORITATE metronidazole CREAM;TOPICAL 020743 NDA Valeant Pharmaceuticals North America LLC 0187-5202 0187-5202-35 3.5 g in 1 TUBE (0187-5202-35)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:CREAM;TOPICALStrength1%
Approval Date:Sep 26, 1997TE:RLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Chubb
Merck
Federal Trade Commission
Boehringer Ingelheim
Accenture
Healthtrust
Cerilliant
UBS
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot